{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:51:31Z","timestamp":1792792291830,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.urology.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T09:38:15Z","timestamp":1532079495000},"page":"205-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-1825","authenticated-orcid":false,"given":"Riad","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hairston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Hohlastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsun","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6636-0189","authenticated-orcid":false,"given":"Ahmed","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kush","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartley","family":"Thornburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Casalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Hamoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samdeep","family":"Mouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2018.07.012_bib0001","unstructured":"McVary KT, Roehrborn CG, Avins AL, et al. American Urological Association guideline: management of benign prostatic hyperplasia (BPH). Urology.36."},{"issue":"Suppl 3","key":"10.1016\/j.urology.2018.07.012_bib0002","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ijir.2008.55","article-title":"Pathology of benign prostatic hyperplasia","volume":"20","author":"Roehrborn","year":"2008","journal-title":"Int J Impotence Res"},{"issue":"5","key":"10.1016\/j.urology.2018.07.012_bib0003","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0004","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"Gratzke","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urology.2018.07.012_bib0005","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2017.07.005","article-title":"Emerging minimally invasive treatment options for male lower urinary tract symptoms","volume":"72","author":"Magistro","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0006","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","article-title":"A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update","volume":"67","author":"Cornu","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0007","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jvir.2016.04.001","article-title":"Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients","volume":"27","author":"Pisco","year":"2016","journal-title":"J Vasc Interventional Radiol: JVIR"},{"key":"10.1016\/j.urology.2018.07.012_bib0008","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.urology.2014.04.028","article-title":"Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study","volume":"84","author":"Kurbatov","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urology.2018.07.012_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.juro.2017.04.072","article-title":"Prostate arterial embolization is a viable option for treating symptoms of benign prostatic hyperplasia: Con","volume":"198","author":"Kaplan","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jvir.2012.12.019","article-title":"Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia","volume":"24","author":"Carnevale","year":"2013","journal-title":"J Vasc Int Radiol: JVIR"},{"key":"10.1016\/j.urology.2018.07.012_bib0011","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1148\/radiol.12111601","article-title":"Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results","volume":"266","author":"Pisco","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2018.07.012_bib0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jvir.2013.09.010","article-title":"Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia","volume":"25","author":"Bagla","year":"2014","journal-title":"J Vasc Interventional Radiol: JVIR"},{"key":"10.1016\/j.urology.2018.07.012_bib0013","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1148\/radiol.13122803","article-title":"Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate\u2013a prospective, randomized, and controlled clinical trial","volume":"270","author":"Gao","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2018.07.012_bib0014","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 Published: May 28 vJ, 2010)."},{"key":"10.1016\/j.urology.2018.07.012_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/nau.22388","article-title":"Rationalization of interpretation of uroflowmetry for a non-Caucasian (Indian) population: conceptual development and validation of volume-normalized flow rate index","volume":"33","author":"Agarwal","year":"2014","journal-title":"Neurol Urodyn"},{"key":"10.1016\/j.urology.2018.07.012_bib0016","first-page":"125","article-title":"Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update","volume":"7","author":"Aoun","year":"2015","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0017","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00270-012-0528-4","article-title":"Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement","volume":"36","author":"Bilhim","year":"2013","journal-title":"Cardiovasc Interventional Radiol"},{"key":"10.1016\/j.urology.2018.07.012_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jvir.2014.10.012","article-title":"Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates >90 g: a prospective single-center study","volume":"26","author":"de Assis","year":"2015","journal-title":"J Vasc Interventional Radiol: JVIR"},{"key":"10.1016\/j.urology.2018.07.012_bib0019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bju.13147","article-title":"Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates","volume":"117","author":"Wang","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.07.012_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","article-title":"Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis","volume":"39","author":"Carnevale","year":"2016","journal-title":"Cardiovasc Interventional Radiol"},{"key":"10.1016\/j.urology.2018.07.012_bib0021","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.juro.2015.10.049","article-title":"Re: the role of prostatic arterial embolization in patients with benign prostatic hyperplasia: a systematic review","volume":"195","author":"Kaplan","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0022","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.juro.2015.01.027","article-title":"Re: Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia","volume":"193","author":"Kaplan","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0023","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00270-016-1443-x","article-title":"Comparative study using 100-300 versus 300-500 mum microspheres for symptomatic patients due to enlarged-BPH prostates","volume":"39","author":"Goncalves","year":"2016","journal-title":"Cardiovasc Interventional Radiol"},{"key":"10.1016\/j.urology.2018.07.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8732351","article-title":"Comparison of nonspherical polyvinyl alcohol particles and microspheres for prostatic arterial embolization in patients with benign prostatic hyperplasia","volume":"2017","author":"Hwang","year":"2017","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.urology.2018.07.012_bib0025","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00270-017-1765-3","article-title":"A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH","volume":"40","author":"Moreira","year":"2017","journal-title":"Cardiovasc Interventional Radiol"},{"key":"10.1016\/j.urology.2018.07.012_bib0026","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrurol.2016.104","article-title":"Getting out of a tight spot: an overview of ureteroenteric anastomotic strictures","volume":"13","author":"Lobo","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0027","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiol.2016152415","article-title":"Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy","volume":"282","author":"Wang","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2018.07.012_bib0028","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jvir.2017.01.004","article-title":"Role of coil embolization during prostatic artery embolization: incidence, indications, and safety profile","volume":"28","author":"Bhatia","year":"2017","journal-title":"J Vasc Interventional Radiol: JVIR"},{"key":"10.1016\/j.urology.2018.07.012_bib0029","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00270-016-1518-8","article-title":"Prostate zonal volumetry as a predictor of clinical outcomes for prostate artery embolization","volume":"40","author":"de Assis","year":"2017","journal-title":"Cardiovasc Interventional Radiol"},{"key":"10.1016\/j.urology.2018.07.012_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOU.0b013e32835abd18","article-title":"Hormonal manipulation of benign prostatic hyperplasia","volume":"23","author":"Rick","year":"2013","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00270-015-1238-5","article-title":"Prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH): Part 2, insights into the technical rationale","volume":"39","author":"Sun","year":"2016","journal-title":"Cardiovasc Interventional Radiol."},{"key":"10.1016\/j.urology.2018.07.012_bib0032","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","article-title":"Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"195","author":"McVary","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0033","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11934-005-0034-1","article-title":"Overactive bladder in the male patient: epidemiology, etiology, evaluation, and treatment","volume":"6","author":"Jaffe","year":"2005","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2018.07.012_bib0034","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.juro.2016.11.045","article-title":"Re: prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.","volume":"197","author":"Kaplan","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.07.012_bib0035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s00270-017-1700-7","article-title":"Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia","volume":"40","author":"Bagla","year":"2017","journal-title":"Cardiovasc Interventional Radiol."}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518307441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518307441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T23:05:32Z","timestamp":1540595132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518307441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":35,"alternative-id":["S0090429518307441"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2018.07.012","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}